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Abstract   
 
Background: Childhood obesity is a rising epidemic worldwide. As risk factors are identified, 
clinicians can help prevent the rising epidemic by educating patients and family members. This 
review looks at the exposure of antibiotics in infancy as a potential risk factor for childhood 
obesity. 
 
Methods:  Exhaustive search of available medical literature was conducted in MEDLINE-Ovid, 
CINAHL, and Web of Science. Keywords used included antibiotic exposure, antibiotic, or 
antibacterial agents and infant and obesity.  
 
Results:  Forty-three articles were reviewed for relevancy, four studies were found to be 
relevant. Only three studies were analyzed in this systematic review, one study was excluded due 
to outcomes being measured less than seven years of age. All three studies showed increased risk 
of children being overweight after exposure to antibiotics in infancy.  Two studies did further 
analysis on risk of childhood weight concerns in boys compared to girls. These two studies 
showed boys had an increased risk of childhood overweight compared to girls. The overall 
quality of the studies was low and further studies need to be completed looking at larger and 
more diverse populations with longer follow up periods. 
 
Conclusion:  Knowing that early exposure to antibiotics during infancy could be a risk factor for 
childhood weight concerns, including obesity, clinicians can use this information as another 
consideration in decreasing the amount of prescribed antibiotics in infancy and to educate 
parents and patients on prevention of childhood obesity. 
 
Keywords: Antibiotic exposure, antibiotic, antibacterial agents, infant, obesity 
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Antibiotic Exposure in Infancy Can Be a factor of Increased 
Risk of Childhood Obesity 
BACKGROUND 
 Childhood obesity is a rising concern and can have a lasting impact on the future health 
of a child.  According to Ogden et al,1 in 2009-2010, 16.8% of US children had a body mass 
index (BMI) of > the 95th percentile according to the BMI-for-age growth charts. It is important 
to understand the many contributing factors that can lead to or influence obesity. Obesity can 
have short term and long term health, social, and economic consequences, that can have a lasting 
impact on one’s overall well being. Cardiovascular and metabolic complications are among the 
top health concerns arising from childhood obesity, along with the psychosocial implications.2 
Due to these potential life-changing complications, it is important to understand the possible 
environmental factors that could be contributing to the increased incidence of childhood obesity.  
 Thirty-one potential risk factors have been reported to be likely contributors to the 
increased incidence of childhood obesity.2,3 If scientists can understand or predict what 
contributes to childhood obesity, there is a chance of preventing the increased incidence. At this 
time, there is limited scientific data and evidence as to the exact risk factors for childhood 
obesity.2,3 According to the Institute of Medicine Committee on Obesity, maternal pre-pregnancy 
BMI, nutritional intake, physical activity, sleep duration, and screen time were identified as 
factors increasing childhood obesity. They noted one additional factor that is of increased 
interest, which is the role of the microbiome of the gut.2-4 More specifically scientists are 
interested at looking at antibiotic exposure and the influence antibiotics have on the gut 
microbiome. Antibiotics can change gut flora, theoretically contributing to increased obesity.4 
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 The microbiome is important in the development of humans and much of the microbiome 
is influenced in early infancy. While in the womb, one is considered to be in a sterile 
environment, but once born and out of the womb, the infant becomes exposed to numerous 
bacteria, which become colonized in the gut. Environmental factors such as genetics, mode of 
delivery, infant feeding patterns, antibiotic usage, sanitary living conditions, and long term 
dietary habits are all considered important contributors to how the gut is shaped and what the gut 
microbiome is composed of.5 Gut colonization occurs early in childhood2 and is said to be 
unstable until around two to three years of age. Combined with this knowledge of gut instability 
in infancy, looking at exposure to antibiotics during infancy, which are known to alter gut 
bacteria, becomes important. This alteration in gut bacteria has been studied in animals and have 
been shown to be linked to antibiotic exposure.5,6 Antibiotics have been given in low doses in 
farm animal feed to fatten them to be sold on the market. A previous study7 on animals with 
antibiotic exposure earlier in life, have shown a connection to increased weight gain. Gut 
microbiota contribute to metabolism of animals and if this gut microbiome is altered, metabolism 
is altered, potentially leading to increased weight.7 With the knowledge of alteration of the gut 
microbiome due to antibiotic use in farm animals, farmers intentionally add low dose antibiotics 
to their feed to increase weight. This has now been restricted and antibiotics can no longer be 
used in veterinary foods due to the known growth-promoting effect.7,8 This data is important as it 
can translate to the human gut, causing alteration of the gut microbiome, leading to increased 
risk of obesity after exposure to antibiotics. Can antibiotic exposure in infancy increase the risk 
of childhood weight concerns such as obesity, later on in life?  
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METHODS 
 An exhaustive search of the literature was performed using MEDLINE- Ovid, CINAHL, 
and Web of Science. Keywords used included: antibiotic exposure, antibiotic, or antibacterial 
agents, and infant, and obesity. Bibliographies of studies and other relevant articles were 
searched for further sources. The articles were included if they were human studies, measured 
outcomes after 7 years of age, or were published in the English language. Articles were assessed 
for quality using the Grading of Recommendations, Assessment, Development, and Evaluation 
(GRADE).9 
RESULTS 
 A total of 43 articles were reviewed for relevancy. Of the articles that were reviewed, 
three articles fit inclusion criteria. All three studies were cohort studies.10-12 One additional study 
was published4, but was excluded from this systematic review due to outcomes of the study 
being measured less than 7 years of age. All other studies measured outcomes at 7 years of age 
or greater. No additional articles were found by searching the references of the included studies. 
See Table 1. 
Trasande et al 
 This longitudinal cohort study10,13 looked at exposure to antibiotics during three early life 
time periods and body mass at five time periods. Study participants were recruited from the 
ALSPAC landmark longitudinal birth cohort study. In order to be included in the study, children 
had to be born weighing > 2500g. Children were excluded if information on antibiotic exposure 
was missing for all three-time windows. The study cohort included 11 532 children. The groups 
were prognostically balanced, although the antibiotic exposure group had a larger number of 
children compared to the group not exposed to antibiotics.10,13 
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 The study outcomes were directed at looking at weight-for-length Z scores, BMI Z-score, 
being overweight (defined as BMI 85-94th percentile for age and gender), and being obese 
(defined as > 95th percentile for age and gender). Weight-for-length was measured at 6 weeks, 10 
months, and 20 months of age. BMI was measured at 38 months and 7 years.10,13 
 The study used multivariable models that included potential confounders. The study 
analyzed prevalence of primary outcomes and then the authors tested the relationship between 
exposure to antibiotics and potential confounders by using the chi-squared test for association. 10 
 The study results showed that antibiotic exposure less than six months of age was 
consistently associated with increases in body mass. When kids were exposed at less than 6 
months of age, BMI scores were significantly higher and the participants were 22% more likely 
to be overweight than children who were never exposed. When looking at children exposed 
during 6-14 months of age, there was no association with increased childhood obesity; however 
the children who were exposed during the ages of 15-23 months had elevated BMI scores at 7 
years of age. These results suggest that exposure to antibiotics at a younger age can cause obesity 
later in life.10 See Figure 1. 
 The researchers identified the limitations to this study to include social, behavioral, and 
biological factors. Parental BMI, maternal smoking, socioeconomic class, sedentary behavior, 
and sleep patterns could all be confounders to the data. However, the ALSPAC study controlled 
for many of the confounders by using multivariate analysis. Another important limitation to 
consider is the study only included children born > 2500g. The authors state that the cohort could 
have included children with normal birth weight, but may have had underlying substantial 
illnesses that could have factored into increased obesity.10,13 
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Azed et al 
 This study11,14 was a nested case-control study that measured total adiposity at ages 9 and 
12 years of age and central adiposity at age 12. This study originated from the SAGE 
longitudinal birth cohort study. Surveys were mailed to all Manitoba children born in 1995 and 
who still were residing in Manitoba at age 7 years. There were 3598 surveys that were returned 
and the nested case-control study was developed with 723 children. Children were included in 
the study if they had prescription records and anthropometric data. There were 107 children who 
were excluded from the study due to prescription records being unavailable.11,14  
 Study outcomes evaluated total adiposity at age 9 and 12 years of age based on BMI 
measurements and central adiposity measured at age 12 based on waist circumference, with the 
primary exposure of any antibiotic exposure in the first year of life. Azad et al defined a child 
being overweight if the BMI was > the 85th percentile and high central adiposity was defined as 
waist circumference > the 75th percentile. Both BMI and high central adiposity measurements 
were according to the published age and sex-standardized reference charts by US Centres for 
Disease Control.11,14 
 This study used multiple logistic regression analysis to determine the likelihood of being 
overweight or of having high central adiposity according to antibiotic exposure during the first 
year of life.  The authors corrected for potential confounders with their analysis. The study had 
case and control groups that were prognostically balanced, although the control group was larger 
than the case group. There were 185 children who were lost to follow up at age 12.11 
 The study results indicated that of the 616 children included in the study, 71.1% of them 
received antibiotics before their first birthday. At age 9, prevalence of overweight children was 
29.4% and 28.1% at age 12. High central adiposity was 33.9% at age 12. When looking at 
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antibiotic exposure and the outcomes of being overweight and having central adiposity without 
correcting for potential confounders, children exposed to antibiotics were more likely to be 
overweight at age 9 compared to children who had not been exposed to antibiotics (P = 0.003). 
Similar results were shown for being overweight (P = 0.002) and having high central adiposity 
(P = 0.01) at age 12 between children exposed to antibiotics compared to children not exposed to 
antibiotics. After adjusting for potential covariates and known obesity risk factors, infant 
antibiotic exposure remained independently associated with childhood weight concerns and high 
central adiposity. Further analysis identified that boys who were exposed to antibiotics in infancy 
had a five fold increased risk of being overweight at age 12 compared to girls where there was no 
association.11 
 Limitations to this study were identified as the small sample size compared to previous 
studies and the 30% loss to follow up at age 12. Another limitation to this study was they were 
unable to account for antibiotic exposure administered in the hospital setting, as this information 
was not part of the database.11 See Table 2. 
Ajslev et al 
 This study12,15 was a longitudinal prospective study from the Danish National Birth 
Cohort (DNBC) that studied 28 354 mother-child dyads. The DNBC was established in 1997-
2002 and studied the Danish population that was pregnant during this time. There was a 7-year 
follow up period where parents were asked to fill out a questionnaire. Inclusion requirements for 
this study were live born, term delivered singleton births, and mothers who participated in 
interview 1 and in the 7-year follow up. Exclusion criteria included mothers with diabetes, if 
mothers developed gestational diabetes or pre-eclampsia during pregnancy. Siblings were 
excluded, meaning that mothers with their second or more pregnancies were excluded. Children 
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were excluded if they had missing, unrealistic, or different-date time measurements of height and 
weight at the 7-year follow-up.  Also the study excluded children with an age of less than 5 or 
greater than 9 at the 7-year follow-up.12,15 
 Study outcome looked at children being overweight at 7 years of age after exposure to 
antibiotic in infancy (<6 months). This study defined children being overweight by BMI cutoff 
scores by the International Obesity Task Force’s age and sex specific BMI. The study analysis 
took into consideration multiple covariates including maternal age, socioeconomic status, 
maternal pre-pregnancy height and weight, parity, and smoking status. Analysis originally only 
looked at primary exposures, and then analyzed data with covariates and exposures. Analysis 
was done with multiple logistic regressions and compared to the reference group. Each analysis 
was done with the entire cohort and then was split into males and females.12,15 
  The study suggested that the prevalence in 7-year old girls was 10.9% for overweight and 
1.6% for obesity. In 7-year old boys prevalence of overweight was 8.3% and 1.1% for obesity. 
When looking at exposure to antibiotics in infancy and not adjusting for covariates, the OR 
indicated an association for children being overweight (OR 1.20, 95% CI 1.02-1.40). When the 
study adjusted for covariates, the association was not present (OR 1.04, 95% CI 0.79-1.37).12,15 
The study further analyzed gender specific relationships between exposure to antibiotics in 
infancy and children being overweight. Ajslev et al found that antibiotic exposure during infancy 
had an increased risk for both boys (OR 1.33, 95% CI 0.99-1.79) and girls (OR 1.37, 95% CI 
1.01-1.87) when unadjusted for covariates. When the study adjusted for covariates, the 
relationship only persisted in boys (OR 1.75, 95% CI 1.18-2.60).12,15 See Table 3. 
 Limitations to this study include families being lost to follow up, which could potentially 
contribute to the number of overweight children that are represented in this cohort. The study 
 14 
states that there may be selection bias present. Another limitation includes self-measurement of 
the children’s weight and height and some data that was provided was from different dates. 
Although children with different date measurements were excluded from the study, this limited 
the overall number of subjects making this a smaller cohort.12,15 
DISCUSSION  
 This systematic review was able to identify three published articles10-12 that addressed the 
question of whether exposure to antibiotics in infancy can contribute to childhood obesity. These 
three articles10-12 looked at the primary outcome of overweight with a BMI > the 85th percentile. 
All three of these papers evaluated being overweight after age 7. Each study identified that 
exposure to antibiotics in infancy had an increased risk for overweight children although the 
association seemed stronger for male participants. Each study was evaluated using the GRADE 
method and can be seen in Table 1.  
 Another article published by Bailey et al4 in 2014 looked at BMI at visits between 24-59 
months of age after exposure to antibiotics in infancy. This study was not included in the 
systematic review due to the primary outcome being evaluated at such young ages. The results of 
the study show that exposure to broad-spectrum antibiotics during infancy is a risk factor for 
childhood obesity. The results of this study are consistent with the three other studies. 
 The Azad et al11 study further analyzed the antibiotic exposure by type of antibiotic, 
whether it was broad spectrum antibiotic use verse narrow spectrum antibiotic use. Narrow 
spectrum antibiotics were defined as penicillin, cloxacillin, cephalexin, cefadroxil, and 
erythromycin.11 All other antibiotics were classified as broad-spectrum antibitoics. Of the 616 
children, 354 were exposed to broad-spectrum antibiotics during infancy. The study had 
difficulty finding differences with weight status according to antibiotic spectrum due to such a 
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small number of children receiving narrow spectrum antibiotics.11 When the study analyzed 
exposure to broad-spectrum antibiotics and risk of being overweight at age 12 alone, the results 
showed an OR 2.48, 95% CI 1.31-4.68.11 This information can be used to educate clinicians and 
parents that antibiotics are not prescribed without harm and it is important to understand the 
potential risk associated with prescribing antibiotics.  
 There has not been an identified mechanism that answers all of the questions related to 
gut alteration by antibiotics, but there have been studies that have shown that the makeup of gut 
microbiota differs between obese and non-obese individuals.11 With this information and the 
evidence of the three studies evaluated in this systematic review, early life antibiotic exposure 
could be a risk factor for childhood obesity. 
 Based on this research clinicians need to teach parents that antibiotics are not always the 
correct answer. If clinicians do provide antibiotics it is important to teach parents about healthy 
gut bacteria. Also, it may be important to provide patients with probiotics while on a course of 
antibiotics to help promote healthy gut bacteria. Some of these simple tasks could be important 
steps to help reduce the increased risk of childhood obesity caused by antibiotic exposure during 
infancy. 
 However, these studies are not without limitations. Some limitations include cohort size, 
loss to follow up, blinding, recall bias, attrition bias and selection bias (see Table 1). The 
Trasande et al10 study measured exposure to antibiotics by parental recall, which could cause 
bias towards study results as parental recall is imprecise. Azad et al11 had a large loss to follow 
up of 30%, which is a huge limitation to their study. Along with the large loss to follow up, this 
study had a much smaller cohort compared to the other two studies. Although these studies 
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adjusted for the published risk factors, there could be other confounders that have not been 
accounted for in these analyses. 
 Although this research has proven that early antibiotic exposure may carry an increased 
risk for development of childhood obesity, further studies need to be performed. These three 
studies have very low quality of evidence; further observational data with more control over the 
confounders would be useful. 
CONCLUSION 
 These studies have shown a possible increased risk for development of childhood obesity, 
however more studies need to be done to have more reliable data, as the current data has low 
quality. Although the studies showed increased risk of childhood obesity, there are many factors 
that can contribute to this risk. Future studies need to evaluate children for multiple years after 
exposure. With improved study results, clinicians could use the data with more applicability to 
help prevent childhood obesity.   
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Table 1. Characteristics of Reviewed Studies  
Quality Assessment  
 Downgrade Criteria 
Quality 
Study Design Limitations Indirectness Imprecision Inconsistencya Publication bias likely 
Overweight (BMI >85th percentile) Very Low 
Trasande et 
al10 Observational Serious
b Not serious Not serious Not serious No Very Low 
Azed et al11 Observational Seriousc Not serious Seriousd Not serious No Very Low 
Ajslev et al12 Observational Very seriouse Not serious Not Serious
 Not serious No Very low 
High Central Adiposity (Waist circumference >75th percentile) Low 
Azed et al11 Observational Not serious Not serious Serious Not serious No Moderate 
Obese (BMI >95th percentile) Low 
Trasande et 
al10 Observational Serious
c Not serious Not serious Not serious No Low 
aThe three studies evaluated overweight BMI at three different time periods. Two studies evaluated BMI at age 7 and one study evaluated BMI at age 9 and 12 
bTrasande et al study had parental recall for exposure 
cAzad et al study had 30% loss of follow up at 12 years of age 
dSmall sample size 
eThe Ajslev et al study (observational) contained a high risk for selection bias because of high loss to follow up and women being selected from highest pre-pregnancy BMI group 
 
 
 
Table 2. Azed et al11 
Outcome All Children  OR (95% CI) 
Girls 
OR (95% CI) 
Boys 
OR (95% CI) 
Overweight  
9 years old 1.87 (1.23-2.52) 
 1.76 (0.96-3.23) 1.91 (1.08-3.38) 
Overweight  
12 years old 2.16 (1.31-3.58) 1.35 (0.66-2.78) 3.16 (1.51-6.60) 
High Central 
Adiposity  
12 years old 
1.80 (1.14-2.85) 1.57 (0.79-3.11) 1.93 (1.03-3.61) 
 
 
Table 3. Ajslev et al12 
Outcome 
Unadjusted for 
Covariates 
OR (95% CI) 
Adjusted for 
Covariates 
OR (95% CI) 
Overweight  
7 years old  1.20 (1.02-1.40) 1.04 (0.79-1.37) 
Boys: Overweight  
7 years old 1.33 (0.99-1.79) 1.75 (1.18-2.60) 
Girls: Overweight  
7 years old 1.37 (1.01-1.87) 1.09 (0.66-1.79) 
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Figure 1. Trasande et al10 
 
 
 
 
*Figure 1 is from Trasande et al10 and is being used in this review with permission from the author 
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